- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CO2, gadolinium prove utility in uterine fibroids treatment
Carbon dioxide and gadolinium are safe and effective contrast media for uterine artery embolization, according to a study from Johns Hopkins University. Their use provides an alternative for patients who are allergic to conventional iodinated contrast agents, and low doses reduce the risk of nephrogenic systemic fibrosis.
Carbon dioxide and gadolinium are safe and effective contrast media for uterine artery embolization, according to a study from Johns Hopkins University. Their use provides an alternative for patients who are allergic to conventional iodinated contrast agents, and low doses reduce the risk of nephrogenic systemic fibrosis.
Dr. Hyun S. Kim, an assistant professor of radiology at Hopkins, and colleagues evaluated the technique in eight patients with symptomatic fibroids. The patients underwent angiography after injection of about 30 to 40 mL of CO2 using a commercially available microcatheter system. They then received the embolization agent mixed with a low dose of the gadolinium-based contrast agent. This approach worked safely and effectively as contrast media in this group of patients, without major complications (J Vasc Interv Radiol 2007;18 [8]:1021-1027).
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
